Two appearances at the Expo firm technology sea
Adhere to opening up to achieve mutual benefit and win-win results. "Participating in the CIIE is an important opportunity for enterprises to communicate, demonstrate technology and seek cooperation. This is our second participation, and we are still very excited and honored." Liu Yu said.
This Expo, minimally invasive robot Group brought its Tumai robot, it is reported that Tumai robot is the first domestic four-arm endoscopic surgery robot approved by NMPA, in September this year, Tumai robot multi-department registration certificate approved by the State Drug Administration (NMPA), can be applied to urology, general surgery, thoracic surgery, gynecology minimally invasive surgery. It is equipped with highly flexible wrist-rotating surgical instruments, immersive naked eye 3D endoscopic system can provide stereoscopic real three-dimensional surgical field of view, intuitive master-slave teleoperation system is very sensitive, which can simplify surgical operation and shorten surgical time.
In terms of clinical data, as of the end of October this year, Tumai robot has completed more than 1,500 cases of auxiliary clinical verification operations in urology, hepatobiliary surgery, gastrointestinal surgery, thoracic surgery, obstetrics and gynecology, and thyroid and breast surgery departments in more than 50 hospitals in 20 provinces across the country, comprehensively covering the difficult and complex operations of pelvic cavity, abdominal cavity and chest cavity.
Liu Yu introduced that Tumai robot has completed all the difficult surgeries in multiple departments, setting a clinical record of the "first domestic" robot surgery of many surgical methods, indicating that it has good clinical adaptability and is becoming more mature in clinical application, which can fully meet the clinical requirements of multi-departments and help the hospital clinical and scientific research continue to achieve high-quality development.
As the industry gradually develops and matures, and the pace of high-value medical consumables centralized procurement in China's medical industry continues to accelerate, domestic medical equipment "going to sea" has become the general trend. Liu Yu introduced that Minimally invasive Robot Group has already laid out the global market at the beginning of its listing. In recent years, through overseas marketing, overseas participation, overseas registration application, overseas installation trial and other ways to take the initiative to "go out", firm technology to the sea, strengthen exchanges with domestic and foreign doctors.
5G telemedicine is the direction that Minimally Invasive Robotics Group continues to explore
With the rapid development of modern science and technology, the medical field has also ushered in revolutionary breakthroughs. Adhering to the belief that "there is no difficult surgery in the world", Minimally invasive Robotics Group has been focusing on 5G remote surgery exploration and practice in recent years.
It is reported that since the first ultra-remote urological surgery was completed in cooperation with Jiangsu Provincial People's Hospital in June 2022, Minimally invasive Robot Group and Zhejiang University School of Medicine affiliated Run Run Shaw Hospital, Gansu Provincial People's Hospital, Zhejiang University School of Medicine affiliated Hospital, 301 Hospital Seventh Medical Center, the first affiliated Hospital of Zhengzhou University, Fudan University Affiliated Obstetrics and Gynecology Hospital, Zhejiang Provincial People's Hospital, Hebei Medical University Fourth Hospital and Shanghai Chest Hospital and other famous domestic first-class hospitals The cooperation has carried out more than 70 5G remote robotic operations in Xinjiang, Gansu, Fujian, Henan, Ningxia, Guizhou, Hebei and other regions, covering a wide range of difficult and complex operations in the fields of general surgery, urology, thoracic surgery, and gynecology. The longest surgical distance is more than 5,000 kilometers, and has created the world's first or difficult surgical records such as radical resection of prostate cancer, radical resection of kidney cancer, radical resection of bladder cancer, liver resection, splenic and pancreatic tail tumor resection, radical gastrectomy, hysterectomy, and radical resection of prostate cancer.
Liu Yu introduced that 5G remote surgery can cross the barrier of time and space to achieve remote surgery operation, on the one hand, reduce the loss of the patient's medical journey time and economic cost, achieve early diagnosis and early treatment, and reduce the delay of disease. At the same time reduce the malpractice of uneven distribution of medical resources. Moreover, because the surgical robot has the characteristics of high precision, high stability and high flexibility, it can reduce the surgical trauma, blood loss and reduce the infection rate.
"5G telemedicine can realize the support of state-level high-level hospitals to less-developed areas, and realize the remote sharing of top medical technology, top equipment resources, and top physician teams, which is in line with the strategic policy of the construction of national regional medical centers." Therefore, this is the direction that Minimally Invasive Robotics Group continues to practice." Liu Yu said.
Focus on core technologies to contribute to the effective sharing of medical resources
In addition to the Tumai robot exhibiting at the Expo, Microinvasive Robot Group also owns Dragonfly eye three-dimensional electronic laparoscopic system, Swan Orthopedics surgery robot, Mona Lisa prostate puncture robot, R-ONE vascular interventional surgery robot, bronchoscopy robot and other products. Over the years, Minimally invasive Robot Group has focused on the industrial strategic layout of surgical robot products. Through two modes of independent research and development and international in-depth industrial cooperation, the research and international cooperation products have covered six "golden tracks" : endoscopy, orthopedics, vascular intervention, natural cavity passage, percutaneous puncture and medical and aesthetic surgical robots. Liu Yu introduced, "The Group's independent research and development of Toumai, Dragonfly eye, Honghu and Mona Lisa four products have been approved by the National Medical Products Administration NMPA listing, laying an important foundation for high-end medical equipment localization and marketization."
Looking at the current surgical robot market, domestic endoscopic robots show the largest share, the operation volume is increasing year by year, but the market penetration is insufficient, and the penetration rate is low.
In this regard, Liu Yu said that surgical robots are a high-threshold field that requires continuous innovation and breakthroughs. In order to stand out in the field of surgical robotics, it is necessary to focus on core technologies, solve the pain points of enterprises and hospitals, and embed the doctor's experience and process into the product, so as to improve the competitiveness and added value of the product, and meet the needs and expectations of the market. Regarding the development plan of Minimally invasive Robot Group, Liu Yu shared, "Our plan is to continue to deepen the six major areas of robotic surgery, grinding products, in-depth technical research and research, to bring better clinical operating experience, and bring the convenience of intelligent technology to patients." By strengthening medical cooperation, fully listening to clinical needs, constantly absorbing feedback and suggestions, and promoting continuous optimization and iteration of various track products."
At the same time, Liu Yu said that the future direction of domestic surgical robots is not only intelligent, but also inclusive, and should let the service sink to the grassroots level to benefit more patients. "With this in mind, we will continue to research and develop 5G remote robotic surgery, contributing to the balanced distribution of medical resources and strengthening the effective sharing of medical resources."
Source: Xinhua
